Luminex Blog | Clinical Diagnostics and Life Sciences
Customer Center
Login | Register

Luminex Licensed Technologies Partner Spotlight: Radix BioSolutions

August 15th, 2018 / Hilary Graham

Custom assay development At Radix, scientists design and manufacture Luminex assays so their customers can focus on what they’re really interested in: the results. The company is one of our Licensed Technologies Partners, a group that includes a wide range of markets, organization types, and locations. All of the Licensed Technologies Partners conduct work that

Continue reading »

The Faces of Luminex: Victoria Gutierrez, Global Events

August 10th, 2018 / Christine Valle

Successful trade shows and events require strong leadership to align tactics with the strategic initiatives of marketing and sales teams—and that’s where Victoria Gutierrez, Senior Manager of Global Events, comes in. The Texas State University ‭graduate and proud Bobcat joined Luminex in 2013 and has been bringing our event strategy to life ‭ever since. She

Continue reading »

Webinar: xMAP® Technology Drives Development of Prostate Cancer Detection Assay

August 8th, 2018 / Hilary Graham

Better test accuracy reduces the need for invasive biopsy procedures For a startup company striving to deliver diagnostics that improve health care for patients who may have prostate cancer, Luminex’s xMAP® Technology is a critical tool in the assay development process. According to a webinar presentation from Ramy Huber, a research associate at ProteoMediX, the assay

Continue reading »

MLO Article: New Testing Guidelines and Studies for C. difficile

August 2nd, 2018 / Christine Valle

Earn continuing education credits in this review of screening, the NAP1 marker, and more A new continuing education article in Medical Laboratory Observer offers a look at improved approaches to testing for Clostridium difficile. The piece comes from our own Sherry Dunbar, Senior Director of Global Scientific Affairs, and can be used to earn continuing

Continue reading »

ASM Workshop: Multiplex Molecular Testing for GI Cases

July 31st, 2018 / Christine Valle

Clinical lab experts share results of EP Test for VERIGENE® System At this year’s ASM Microbe meeting, two clinical lab experts presented updates and personal experiences about GI testing in a Luminex-sponsored workshop. The talks covered recent updates to clinical practice guidelines for infectious diarrhea and Clostridium difficile, the rationale for multiplex molecular tests, and a

Continue reading »

Webinar Wednesday: For Tracking Anti-Apoptosis Proteins, Scientists Turn to Multiplexing

July 25th, 2018 / Hilary Graham

AbbVie team uses Luminex-based immunoassay for drug discovery applications According to Dr. Lloyd Lam, a senior scientist at AbbVie, measuring the expression of anti-apoptotic proteins such as BCL-2 is an easier and more cost-effective task when done with a multiplex immunoassay. Lam spoke in a Nature webinar entitled “Multiplex assays of the anti-apoptotic BCL-2 family,”

Continue reading »

Webinar: How a Community Hospital Saved $600,000 with Rapid Diagnostics

July 24th, 2018 / Christine Valle

Rapid results help medical teams avoid unnecessary use of broad-spectrum antibiotics Rapid diagnostic testing is a critical component of successful antimicrobial stewardship programs, according to an expert from Blount Memorial Hospital in Maryville, Tennessee. In a recent webinar, Clinical Pharmacy Specialist Brad Crane shared his story of implementing rapid diagnostic testing at his non-teaching community

Continue reading »

ARIES® GBS Assay Outperforms Culture Testing in a Multisite Study

July 19th, 2018 / Christine Valle

Results show excellent clinical performance, sensitivity, specificity, reproducibility, and ease of use A new publication released in the Journal of Clinical Microbiology reports results of a multisite analysis of the ARIES® GBS Assay. Lead author Diana R. Hernandez from Geisinger, senior author Arundhati Rao from Baylor Scott and White Health, and collaborators issued their findings

Continue reading »

How to Multiplex Analysis of Autoimmune Biomarkers

July 11th, 2018 / Hilary Graham

At Protagen, scientists enlist xMAP® Technology to characterize autoantibodies Multiplex analysis of autoantibodies is an effective way to understand autoimmune disease, discover important biomarkers, and stratify patients into subgroups, according to Hans-Dieter Zucht, Head of Technology at Protagen. The company uses a biomarker discovery platform for autoimmune disease and immuno-oncology applications. In a presentation about autoantibody

Continue reading »

Master the Art of Multiplexing with Hands‑on Training

July 6th, 2018 / Terrin Blackmon

Special event starting in September Don’t be intimidated by multiplexing. Join Luminex experts for a training event the week of September 17, 2018 in Austin, TX. Register for Customer Week Learning Sessions today! Develop Your Multiplexing Skills Our training sessions are designed to be comprehensive – covering the instrument, software, and assay development. Our content is

Continue reading »